TUKOL
Live / Registered — Registered and renewed (as of 13 May 2021)
What this means for you
Registered since 27 Dec 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Dec 2031: the §8 & §9 renewal).
Record
- Serial number
- 77880370
- Registration number
- 4075665
- Mark type
- Word mark
- Filed
- 24 Nov 2009
- Published for opposition
- 05 Jul 2011
- Registered
- 27 Dec 2011
- Current term from
- 27 Dec 2021
- Next maintenance filing
- §8 & §9 renewal, due by 27 Dec 2031 (grace period to 27 Jun 2032)
- Attorney of record
- Kirstin M. Jahn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical antitussive-cold preparations
Owner
- Genomma Lab Internacional, S.A.B. de C.V., Mexico City, MX
- Genomma Lab Internacional, S.A.B. de C.V., Col. Juarez Mexico, DF, MX
- Genomma Lab Internacional, S.A.B. de C.V., Col. Juarez Mexico, DF, MX
Board proceedings on this mark
- Extension of Time to Oppose No. 77880370 — Bristol-Myers Squibb Company v. Genomma Lab Internacional, S.A.B. de C.V, filed 29 Jul 2011 (Terminated)
Prosecution history
- 29 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 May 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 May 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 May 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 11 May 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 May 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 May 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 May 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED